Background: Hospital-based violence intervention programs (HVIP) aim to reduce violent-injury recidivism by providing intensive, case management services to high-risk patients who were violently injured. Although HVIP have been found effective at reducing recidivism, few studies have sought to identity how long their effects last. Additionally, prior studies have been limited by the fact that HVIP typically rely on self-report or data within their own healthcare system to identify new injuries. Our aim was to quantify the long-term recidivism rate of participants in an HVIP program using more objective and comprehensive data from a regional health information exchange (HIE). Methods: The study included 328 patients enrolled in Prescription for Hope (RxH), an HVIP, between January 2009 and August 2016. We obtained RxH participants' emergency department (ED) encounter data from a regional HIE database from the date of hospital discharge to February 2017. Our primary outcome was violent-injury recidivism rate of the RxH program. We also examined reasons for ED visits that were unrelated to violent injury. Results: We calculated a 4.4% recidivism rate based on 8 years of statewide data, containing 1,575 unique encounters. Over 96% of participants were matched in the state database. Of the 15 patients who recidivated, only 5 were admitted for their injury. Over half of new violence-related injuries were treated outside of the HVIP-affiliated trauma center. The most common reasons for ED visits were pain (718 encounters), followed by suspected complications or needing additional postoperative care (181 encounters). Substance abuse, unintentional injuries, and suicidal ideation were also frequent reasons for ED visits. Conclusion: The low, long-term recidivism rate for RxH indicates that HVIP have enduring positive effects on the majority of participants. Our results suggest HVIP may further benefit patients by partnering with organizations that work to prevent suicide, substance use disorders, and other unintentional injuries. Level of Evidence: Therapeutic study, level III. (C) 2017 Lippincott Williams & Wilkins, Inc.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2vJcAfv
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
[PDF] Καρκίνος του στομάχου -- Αλέξανδρος Γ. Σφακιανάκης Αναπαύσεως 5 Άγιος Νικόλαος Λασιθίου 72100 2841026182
-
P2Y2 Nucleotide Receptor Is a Regulator of the Formation of Cardiac Adipose Tissue and Its Fat-Associated Lymphoid Clusters P2Y2 Nucleotide ...
-
Rehab patients are friends and co-workers, which requires additional awareness for rehab medical personnel and preplanning to administer ove...
-
Abstract Introduction In recent years, platelet-rich plasma (PRP) has emerged as a promising autologous biological treatment modality fo...
-
Tales from the Night:: Emergency MR Imaging in Pediatric Patients after Hours Publication date: May 2019 Source: Magnetic Resonance Imaging...
-
blood bank stuff: The basics of crit care transfusion medicine EMCrit by Scott Weingart . from Emergency Medicine via xlomafota13 on I...
-
DELAYED RESPONSE: It is yet another delayed ambulance response to an emergency in D.C. With no ambulance in sight, a man suffering from mult...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου